Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Neptune Technologies & Bioresources Inc (NEPT) 2.98 -0.045
Price Open:2.98Day's Range:0.00000 - 4.19
Price Close:3.01552wk Range:0.00000 - 5.14
Price Day Change:-0.045Volume:79,430
Price % Change:-1.49Market Cap:178.4M
Bid:2.97000PE Ratio:0
Ask:2.98000EPS Diluted:-0.321
Trade NEPT NOW!

The Latest On NEPT

Benzinga's Top Initiations 2/15/13 8:54am
Benzinga's Small Cap Movers for Tuesday January 15, 2013 1/15/13 7:16pm
Neptune Technologies Shares Modestly Lower as Its Acasti Unit Offers Clinical Trial Results for CaPre 12/17/12 11:38am
Morning Market Losers 11/27/12 10:58am
Neptune Technologies Unveils Action Plan to Resume Operations 11/26/12 6:51pm
Upcoming Dividend Leak Spurs More Buying For Neptune 6/28/12 1:44pm
Neptune Technologies & Bioressources Confirms Total Orders Amounting to $25M for 2013 6/21/12 8:50am
Neptune's Allowance of Continuation of '348 Patent Strengthens Its Position in the U.S. 6/7/12 8:03am
Neptune Reports Preliminary Revenues on First Quarter of $6-6.2M vs $5.54M Est 6/5/12 8:03am
Neptune Confirms Its Pre-eminence in the Australian Market 5/8/12 8:05am
Technical and Fundamental Reasons Why Neptune (NEPT) Should Be In Your Portfolio 4/25/12 6:17am
Neptune Says Must Again Rectify Competitor's Misleading Statement 3/1/12 9:03am
more
Press Releases
Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sustained Patent Infringement 5/15/13 GlobeNewswire
Class Action Lawsuit Against Neptune Dismissed 5/15/13 GlobeNewswire
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2013 Results 5/9/13 GlobeNewswire
The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation Based on Neptune & Acasti Complaint 4/15/13 GlobeNewswire
Neptune Provides Update on European Patent Dispute and Maintains Its International Patent Strategy 4/10/13 GlobeNewswire
Neptune to Present at the Annual ROTH Conference 3/14/13 GlobeNewswire
Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further Bolstering Neptune's Request for an ITC Investigation 2/26/13 GlobeNewswire
Neptune Responds to Aker BioMarine's Attempt to Shift the Focus From Neptune's Major ITC Filing 1/31/13 GlobeNewswire
Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Neptune Technologies & Bioressources Inc. 1/26/13 Business Wire
Neptune Obtains Allowance of Patent Specific to Krill Oil and Announces Management Reorganization 1/24/13 GlobeNewswire
Neptune Reports Third Quarter Results and Confirms First Insurance Payment 1/15/13 GlobeNewswire
Neptune to Hold Conference Call 1/14/13 GlobeNewswire

Get the latest NEPT stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Neptune Technologies & Bioresources Inc stock price.

Partner Headlines
Community Health Systems, Orexigen Therapeutics Among Stocks Setting 52-Week Highs Thursday 6/28/12
Elan Corporation plc, Quest Software Among Stocks Up on High Volume Friday 5/25/12
10 Cheap Biotech Stocks That Could Soar
8 Stocks Under $10 Moving Higher
8 Stocks Under $10 Moving Higher
5 Stocks Poised for Breakouts
5 Names Seeing Bullish Flow
5 Names Seeing Bullish Flow